US Apple Watch Import Ban: A Swift Overview

US Apple Watch Import Ban: A Swift Overview
The recently imposed import ban on Apple Watches in the United States has left consumers and Apple contemplating the next moves. Ordered by the US International Trade Commission (ITC) in response to a complaint from Masimo, a medical-tech firm, the ban stems from alleged infringement on pulse oximetry patents related to blood-oxygen level readings.
Immediate Impact:
Apple preemptively halted sales of its Series 9 and Ultra 2 models in the US before the Christmas Day deadline, complying with the ITC's order. However, the ban excludes the lower-priced Apple Watch SE, lacking pulse-oximetry features.
Accusations and Legal Battles:
Masimo accuses Apple of poaching employees and stealing technology after collaborative discussions. Legal battles, including a mistrial in May, continue. Apple countersued Masimo for patent infringement.
Apple's Options:
Apple plans to appeal to the US Court of Appeals but faces challenges as the ITC rejected a pause during the appeal. Efforts to modify software for patent compliance are underway, potentially allowing resumption of imports pending US Customs and Border Protection approval.
Uncertain Resolution:
Masimo's insistence on hardware patent coverage and CEO Joe Kiani's openness to a settlement add complexity to the resolution of this high-stakes dispute. The future of Apple Watch imports and sales in the US remains uncertain.